3 ms·
It’s definitely an accomplishment but that wasn't a key differentiator: Moderna’s vaccine candidate was ready in February and Pfizer’s timing was similar, too.
by acdha 6y ago
It’s definitely an accomplishment but that wasn't a key differentiator: Moderna’s vaccine candidate was ready in February and Pfizer’s timing was similar, too. The difference was that they did the required large scale phased testing and I’m sure that will be the subject of medical ethics discussions for decades. One of the really interesting questions would be how you could approve something like the mRNA delivery mechanism independent from the targeted protein to allow a quick response, as they’re doing now with tweaks targeting new COVID variants.